Higher open foreseen for markets


Stock futures pointed to a higher opening for Canada's main stock index on Tuesday ahead of the U.S. Federal Reserve's two-day meeting as investors wait for clues about the timing of any interest rate hike.

The S&P/TSX composite index remained 74.82 points to end Monday at 14,469, with December springing up 0.5% Tuesday.

The Canadian dollar picked up 0.16 cents to 89.04 cents U.S. early Tuesday.

Founder Anthony Lacavera is stepping down as chief executive officer of fledgling Canadian wireless operator Wind Mobile, the company said on Monday, just weeks after he brokered new financing that made him one of Wind's largest shareholders.

Canada Pension Plan Investment Board plans to invest about one billion reais ($396 million) in commercial property in Brazil, a few months after the Toronto-based pension fund opened an office in São Paulo.

Barclays cut the rating on Baytex Energy to equal weight from overweight

Barclays also cut the rating on Crescent Point Energy to equal weight from overweight.

Canaccord Genuity raised the rating on Maple Leaf Foods to buy from hold.

ON BAYSTREET

The TSX Venture Exchange dropped 15.10 points Monday to 790.35.

ON WALLSTREET

U.S. stock index futures rose on Tuesday ahead of data on industrial production, home prices and consumer confidence and as the Federal Reserve prepared to begin a two-day meeting on monetary policy.

Ahead of the opening bell, futures for the Dow Jones Industrials gathered 68 points, or 0.4%, to 16,824. Futures for the S&P 500 picked up 8.75 points, or 0.5%, to 1,965.75, and futures for the NASDAQ advanced 21.25 points, or 0.5%, to 4,059.50.

Twitter shares fell 13.1% in pre-market trading a day after it posted a slide in a closely watched measure of engagement even as its user base grew in the third quarter.

Receptos Inc shares jumped 33% pre-market after the company said its experimental ulcerative colitis drug met the main goal in a mid-stage trial.

U.S.-traded shares of Sanofi dropped 8% pre-market after the French drug maker said sales growth at its leading business of diabetes treatments would stall next year.

A busy economic schedule includes September data on durable goods, S&P/Case-Shiller home prices for August and a gauge of consumer confidence for October.

The U.S. Federal Reserve begins later on Tuesday a two-day meeting, after which it is expected to reinforce expectations it will wait a long while before rising interest rates. The U.S. central bank is all but certain to announce the end of its massive bond-buying stimulus.

Oil prices gained 46 cents to $81.46 U.S. a barrel

Gold prices ducked back $2.20 to $1,237.10 U.S. an ounce.

Related Stories